We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AZUL
2226
DELISTED
Azul
AZUL
| $181K | ﹤0.01% |
23,326
-42,786
| -65% | -$339K |
|
2227
Vor Biopharma
VOR
$1.05B
| $181K | ﹤0.01% |
+3,816
| New | +$168K |
|
2228
Latham Group
SWIM
$661M
| $180K | ﹤0.01% |
45,500
-20,900
| -31% | -$59.6K |
|
2229
GrafTech
EAF
$203M
| $176K | ﹤0.01% |
+12,787
| New | +$199K |
|
|
PVBC
2230
DELISTED
Provident Bancorp
PVBC
| $175K | ﹤0.01% |
+19,184
| New | +$192K |
|
|
MRSN
2231
DELISTED
Mersana Therapeutics
MRSN
| $172K | ﹤0.01% |
1,537
-4,775
| -76% | -$475K |
|
2232
Crawford & Co Class B
CRD.B
$496M
| $171K | ﹤0.01% |
+18,905
| New | +$208K |
|
2233
Western New England Bancorp
WNEB
$290M
| $171K | ﹤0.01% |
+22,244
| New | +$185K |
|
2234
Werewolf Therapeutics
HOWL
$22M
| $170K | ﹤0.01% |
+26,284
| New | +$153K |
|
2235
PDS Biotechnology
PDSB
$38.7M
| $163K | ﹤0.01% |
+41,221
| New | +$212K |
|
2236
Rockwell Medical
RMTI
$27.6M
| $162K | ﹤0.01% |
9,783
-7,727
| -44% | -$112K |
|
2237
Lantronix
LTRX
$244M
| $158K | ﹤0.01% |
44,498
+22,948
| +106% | +$113K |
|
2238
Smart Sand
SND
$203M
| $158K | ﹤0.01% |
82,641
-78,775
| -49% | -$151K |
|
2239
CALL
iShares MSCI EAFE ETF
EFA
$76.8B
| $154K | ﹤0.01% |
+1,900
| New | +$145K |
|
2240
Cadiz
CDZI
$259M
| $154K | ﹤0.01% |
53,000
| – | – |
|
2241
Laureate Education
LAUR
$5.25B
| $153K | ﹤0.01% |
+10,500
| New | +$139K |
|
2242
KNOT Offshore Partners
KNOP
$353M
| $151K | ﹤0.01% |
29,340
-15,872
| -35% | -$89.2K |
|
2243
Fastly Inc
FSLY
$3.14B
| $151K | ﹤0.01% |
+11,652
| New | +$197K |
|
2244
MediWound
MDWD
$186M
| $148K | ﹤0.01% |
+10,357
| New | +$142K |
|
2245
AST SpaceMobile
ASTS
$17.4B
| $147K | ﹤0.01% |
+50,597
| New | +$170K |
|
2246
Mama's Creations
MAMA
$825M
| $142K | ﹤0.01% |
28,403
+5,340
| +23% | +$25.3K |
|
|
WEL.WS
2247
CALL
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
| $141K | ﹤0.01% |
12,269
| – | – |
|
2248
Genelux
GNLX
$132M
| $139K | ﹤0.01% |
+21,643
| New | +$197K |
|
2249
Gilat Satellite Networks
GILT
$831M
| $138K | ﹤0.01% |
+25,335
| New | +$152K |
|
2250
Wrap Technologies
WRAP
$99.8M
| $137K | ﹤0.01% |
60,620
+30,810
| +103% | +$104K |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.